These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 26952248)

  • 1. Heart Failure With Preserved Ejection Fraction.
    Reddy YN; Borlaug BA
    Curr Probl Cardiol; 2016 Apr; 41(4):145-88. PubMed ID: 26952248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
    Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
    Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
    Maeder MT; Kaye DM
    Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical dilemma of heart failure with preserved ejection fraction: an update on pathophysiology and management for physicians.
    Irizarry Pagán EE; Vargas PE; López-Candales A
    Postgrad Med J; 2016 Jun; 92(1088):346-55. PubMed ID: 26964562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.
    Salamon JN; Kelesidis I; Msaouel P; Mazurek JA; Mannem S; Adzic A; Zolty R
    J Card Fail; 2014 Jul; 20(7):467-75. PubMed ID: 24858070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing heart failure with preserved ejection fraction.
    Becher PM; Lindner D; Fluschnik N; Blankenberg S; Westermann D
    Expert Opin Med Diagn; 2013 Sep; 7(5):463-74. PubMed ID: 23930995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
    Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
    Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical therapy in heart failure with preserved ejection fraction: A systematic review.
    Palau P; Núñez E; Domínguez E; Sanchis J; Núñez J
    Eur J Prev Cardiol; 2016 Jan; 23(1):4-13. PubMed ID: 25488549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Nichols GA; Reynolds K; Kimes TM; Rosales AG; Chan WW
    Am J Cardiol; 2015 Oct; 116(7):1088-92. PubMed ID: 26235928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition of Left Ventricular Ejection Fraction in Heart Failure.
    Sakata Y; Tsuji K; Nochioka K; Shimokawa H
    Adv Exp Med Biol; 2018; 1067():5-15. PubMed ID: 29516307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approaches.
    Toth PP; Gauthier D
    Postgrad Med; 2021 Mar; 133(2):125-139. PubMed ID: 33283589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology and prognosis of heart failure].
    Edelmann F
    Herz; 2015 Apr; 40(2):176-84. PubMed ID: 25822419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs.
    Chen YT; Wong LL; Liew OW; Richards AM
    Cells; 2019 Dec; 8(12):. PubMed ID: 31888288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart Failure with Myocardial Recovery - The Patient Whose Heart Failure Has Improved: What Next?
    Nijst P; Martens P; Mullens W
    Prog Cardiovasc Dis; 2017; 60(2):226-236. PubMed ID: 28551473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
    Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.
    Xanthopoulos A; Triposkiadis F; Starling RC
    Trends Cardiovasc Med; 2018 Aug; 28(6):392-400. PubMed ID: 29471985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.